Long-term trends grow from short term trends. We attampt to determine the short term trends and where they are pointing.
By Tim McMahon, editor What Are Structured Bonds? First let’s look at what makes up a bond. A bond is a form of debt where a company borrows money from investors and has a certain expiration date called a “Maturity Date”. The interest rate that the company pays is called the “coupon rate.” One advantage […]
Invest in Structured Bonds? Read More »
EWI’s Global Market Perspective foresaw the shift in European banks from lenders to savers via one remarkable chart It’s been over two years since the European Central Bank began its open-heart surgery of the eurozone’s anemic economy. So far, the procedure has included an unprecedented $3 trillion-plus in bailouts, monetary transfusions, AND toxic debt transplants.
European Central Bank: “Great White Fear” Takes A Bite Out of Recovery Read More »
How does the U.S. Tax Rate compare with other countries? Recently the people at Turbo-Tax created a great “info-graphic” comparing world-wide marginal income tax rates so we can see where we stand. According to Wikipedia A marginal tax rate is the tax rate that applies to the last unit of currency of the tax base (taxable
World-Wide Marginal Tax Rates Read More »
By Doug Casey, Casey Research I recently wrote an article that addresses the subject of sociopaths and how they insinuate themselves into society. Although the subject doesn’t speak directly to what stock you should buy or sell to increase your wealth, I think it’s critical to success in the markets. It goes a long way
In March 2012, the Physicians Foundation surveyed 500 physicians aged 40 or younger. 250 were primary care physicians, 175 were Surgical specialists and 75 were hospital based specialists. The typical physician in the survey was 37 years old and employed by a medical group. You would expect these young physicians to be on top of
U.S. Healthcare Trends- Young Docs Not Optimistic Read More »
By Chris Wood, Casey Research As an analyst who spends a great deal of time researching biotech and pharma companies, I’m well aware of the challenges facing the drug industry in the US today. From onerous regulation and an approval process that has made drug development prohibitively costly and complex to the pending patent cliff
Is Animal Testing about to become Obsolete? Read More »
By Jeff Clark, Casey Research Let’s explore the advantages of saving in gold and silver over dollars. Here’s a hypothetical look at what could occur over the remainder of this decade. The charts below compare saving $100/month in gold and silver vs. an interest-bearing money-market account. For our projections, we assumed gold’s average annual gain
Where (and When) to Place Your Investment Bets? Read More »
By Jeff Clark, Casey Research We’ve read mixed reports about how lofty gold and silver prices are affecting demand in India. One month we’re told demand is up, and the next it’s supposedly down. I’m not suggesting that official reports are inaccurate, but it is admittedly confusing and doesn’t help us understand the real trend
By Vedran Vuk, Casey Research Exchange-traded funds have been all the rage in recent years – they are easy to buy, easy to sell, and often have lower expense ratios than index mutual funds. But the Casey Research team dug deep into the complex world of ETFs and found that in many cases, their names
ETFs: Do You Really Know What You’re Buying? Read More »
By Vedran Vuk, Casey Research In the infamous case of the Goldman Sachs Abacus 2007 AC-1 fund, it doesn’t take a whole lot to figure out the wrongdoing. Paulson & Co., a multibillion-dollar hedge fund, helped select the mortgage-backed securities held by Abacus while at the same time, Paulson was planning on shorting it. This
The Pesky Details of Prospectus Disclosure Read More »
